🇺🇸 FDA
Patent

US 11370828

Anti-coronavirus antibodies and methods of use

granted A61KA61K2039/505A61K2039/54

Quick answer

US patent 11370828 (Anti-coronavirus antibodies and methods of use) held by The United States of America, as represented by the Secretary, Department of Health and Human Svcs. expires Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Svcs.
Grant date
Tue Jun 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K2039/505, A61K2039/54, A61K2039/545, A61K39/215